Stock A086060 GENEBIOTECH CO. ,LTD
Add to a list
To use this feature you must be a member
Log inSign up

Company GeneBioTech Co. ,Ltd

Equities

A086060

KR7086060001

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 28/06/2024 am IST 		5-day change 1st Jan Change
3,955 KRW -0.25% Intraday chart for GeneBioTech Co. ,Ltd 0.00% -9.29%
2023 GeneBioTech Co. ,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
2018 GL Pharm Tech Corp. announced that it has received KRW 2 billion in funding from Daone Chemical Co., Ltd., Genebiotech Co., Ltd. CI

Business Summary

GeneBioTechCo.,Ltd. is a company mainly engaged in the production and sale of feed additives and animal drugs. Along with subsidiaries, the Company operates its business through two segments. The Additive segment is involved in the manufacturing and sale of fermented products and bio starches. The Animal Drug segment is involved in the manufacturing and sale of livestock and fish medicine. The main products include vitamins, minerals, antibiotics, nutrients, immune stimulators, digestion and absorption promoters, among others. The Company distributes its products within the domestic market and to overseas markets, including America.

Number of employees: 39

Sales per Business

KRW in Million2022Weight2023Weight Delta
Feed Additives and Functional Foods Product
55.6 %
44,674 54.0 % 44,210 55.6 % -1.04%
Feed Additives and Functional Foods Merchandise
44.4 %
38,085 46.0 % 35,267 44.4 % -7.40%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
100.0 %
82,759 100.0 % 79,477 100.0 % -3.97%

Managers

Managers TitleAgeSince
Chan-Ho Lee CEO
 Chief Executive Officer 60 -
Joo-Sun Park BRD
 Director/Board Member 49 -
Won-Tak Cho BRD
 Director/Board Member 55 -
Yong-Gu Kim PRN
 Corporate Officer/Principal 57 -
Sang-Kyu Choi AUD
 Comptroller/Controller/Auditor 57 -
Jeong-Seon Kang PRN
 Corporate Officer/Principal 60 -

Members of the board

Members of the board TitleAgeSince
Chan-Ho Lee CEO
 Chief Executive Officer 60 -
Jeong-Seon Kang PRN
 Corporate Officer/Principal 60 -
Won-Tak Cho BRD
 Director/Board Member 55 -
Yong-Gu Kim PRN
 Corporate Officer/Principal 57 -
Joo-Sun Park BRD
 Director/Board Member 49 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 8,610,587 6,093,149 ( 70.76 %) 0 70.76 %

Company contact information

Gene Bio Tech Co., Ltd.

166 Sinwonsa-ro Gyeryong-myeon

32619, Gongju

+

http://www.genebiotech.co.kr
address GeneBioTech Co. ,Ltd(A086060)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sector Other Pharmaceuticals

1st Jan change Capi.
GENEBIOTECH CO. ,LTD Stock GeneBioTech Co. ,Ltd
-9.29% 24.63M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+55.32% 819B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.75% 351B
MERCK & CO., INC. Stock Merck & Co., Inc.
+13.56% 329B
ABBVIE INC. Stock AbbVie Inc.
+10.68% 298B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.57% 242B
ROCHE HOLDING AG Stock Roche Holding AG
+2.04% 225B
NOVARTIS AG Stock Novartis AG
+13.31% 217B
AMGEN INC. Stock Amgen Inc.
+8.48% 168B
PFIZER, INC. Stock Pfizer, Inc.
-2.81% 158B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A086060 Stock
  4. Company GeneBioTech Co. ,Ltd